Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
Fei Chen, Saeed Esmaili, Geraint B. Rogers, et al.
Hepatology (2019) Vol. 71, Iss. 4, pp. 1213-1227
Open Access | Times Cited: 275

Showing 1-25 of 275 citing articles:

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N. Newsome, Shiv Kumar Sarin, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 1, pp. 202-209
Open Access | Times Cited: 3173
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1999-2014.e1
Open Access | Times Cited: 2548
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye, Biyao Zou, Yee Hui Yeo, et al.
˜The œLancet. Gastroenterology & hepatology (2020) Vol. 5, Iss. 8, pp. 739-752
Closed Access | Times Cited: 686
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai‐Sun Wong, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 889-919
Open Access | Times Cited: 629
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
Quentin M. Anstee, Rebecca Darlay, Simon Cockell, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 505-515
Open Access | Times Cited: 372
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
Kenneth I. Zheng, Feng Gao, Xiaobo Wang, et al.
Metabolism (2020) Vol. 108, pp. 154244-154244
Open Access | Times Cited: 316
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili, Michael Roden
Molecular Metabolism (2020) Vol. 50, pp. 101122-101122
Open Access | Times Cited: 231
Non-alcoholic fatty liver disease: A patient guideline
Sven Francque, Giulio Marchesini, Achim Kautz, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100322-100322
Open Access | Times Cited: 204
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
Mohammed Eslam, Naim Alkhouri, Pietro Vajro, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 10, pp. 864-873
Closed Access | Times Cited: 202
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 178
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review
Michelle T. Long, Mazen Noureddin, Joseph K. Lim
Gastroenterology (2022) Vol. 163, Iss. 3, pp. 764-774.e1
Open Access | Times Cited: 177
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Ramy Younes, Olivier Govaere, Salvatore Petta, et al.
Gut (2021) Vol. 71, Iss. 2, pp. 382-390
Open Access | Times Cited: 164
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
Mohammed Eslam, Hashem B. El‐Serag, Sven Francque, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 10, pp. 638-651
Closed Access | Times Cited: 158
Metabolic drivers of non-alcoholic fatty liver disease
Kendra K. Bence, Morris J. Birnbaum
Molecular Metabolism (2020) Vol. 50, pp. 101143-101143
Open Access | Times Cited: 153
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Soo Lim, Jin–Wook Kim, Giovanni Targher
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 7, pp. 500-514
Closed Access | Times Cited: 147
Management of non-alcoholic fatty liver disease
Maria Letizia Petroni, Lucia Brodosi, Elisabetta Bugianesi, et al.
BMJ (2021), pp. m4747-m4747
Open Access | Times Cited: 144
Association of metabolic dysfunction-associated fatty liver disease with kidney disease
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 4, pp. 259-268
Open Access | Times Cited: 138
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
Björn Carlsson, Daniel Lindén, Gabriella Brolén, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 51, Iss. 12, pp. 1305-1320
Open Access | Times Cited: 136
Lifestyle interventions in nonalcoholic fatty liver disease
Zobair M. Younossi, Shira Zelber‐Sagi, Linda Henry, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 11, pp. 708-722
Closed Access | Times Cited: 125
The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040
Takanori Ito, Masatoshi Ishigami, Biyao Zou, et al.
Hepatology International (2021) Vol. 15, Iss. 2, pp. 366-379
Closed Access | Times Cited: 116
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis
Ansel Shao Pin Tang, Cheng Han Ng, Poh Hui Phang, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 7, pp. 1750-1760.e12
Closed Access | Times Cited: 74
Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)
Oumarou Nabi, Nathanaël Lapidus, Jérôme Boursier, et al.
Hepatology (2023) Vol. 78, Iss. 1, pp. 272-283
Open Access | Times Cited: 55
What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside
Pojsakorn Danpanichkul, Kanokphong Suparan, Donghee Kim, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 278-278
Open Access | Times Cited: 21
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa
Gamal Shiha, Khalid Alswat, Maryam Al Khatry, et al.
˜The œLancet. Gastroenterology & hepatology (2020) Vol. 6, Iss. 1, pp. 57-64
Closed Access | Times Cited: 135
Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis
Steven Young, Raseen Tariq, John Provenza, et al.
Hepatology Communications (2020) Vol. 4, Iss. 7, pp. 953-972
Open Access | Times Cited: 124
Page 1 - Next Page

Scroll to top